Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NASDAQ:DFFN

Diffusion Pharmaceuticals (DFFN) Stock Price, News & Analysis

Diffusion Pharmaceuticals logo

About Diffusion Pharmaceuticals Stock (NASDAQ:DFFN)

Key Stats

Today's Range
N/A
50-Day Range
$4.38
$6.60
52-Week Range
N/A
Volume
351,000 shs
Average Volume
10,937 shs
Market Capitalization
$8.98 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Diffusion Pharmaceuticals Inc., a biopharmaceutical company, develops novel therapies that enhance the body's ability to deliver oxygen. Its lead product candidate is Trans Sodium Crocetinate that is developed to enhance the diffusion of oxygen to tissues, as well as to treat COVID-19 disease. The company was founded in 2001 and is based in Charlottesville, Virginia.

Receive DFFN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Diffusion Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

DFFN Stock News Headlines

Diffusion Pharmaceuticals Inc.
The most productive 1 min of your day…
This next step in your trading career is a simple, yet important one. I want you to take 1 minute to sign up for FREE algo alerts powered by StocksToTrade.
See More Headlines

DFFN Stock Analysis - Frequently Asked Questions

Diffusion Pharmaceuticals Inc. (NASDAQ:DFFN) posted its quarterly earnings data on Wednesday, November, 10th. The company reported ($9.00) EPS for the quarter, missing analysts' consensus estimates of ($3.00) by $6.00.

Diffusion Pharmaceuticals shares reverse split before market open on Thursday, August 17th 2023. The 1-1.5 reverse split was announced on Thursday, August 17th 2023. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, August 17th 2023. An investor that had 100 shares of stock prior to the reverse split would have 67 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that Diffusion Pharmaceuticals investors own include Tonix Pharmaceuticals (TNXP), Onconova Therapeutics (ONTX), OPKO Health (OPK), T2 Biosystems (TTOO), NightHawk Biosciences (NHWK), Sorrento Therapeutics (SRNE) and TherapeuticsMD (TXMD).

Company Calendar

Last Earnings
11/10/2021
Today
10/31/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:DFFN
Employees
13
Year Founded
N/A

Profitability

Net Income
$-15,590,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$6.97 per share

Miscellaneous

Free Float
2,003,000
Market Cap
$8.98 million
Optionable
Not Optionable
Beta
1.78
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

This page (NASDAQ:DFFN) was last updated on 10/31/2024 by MarketBeat.com Staff
From Our Partners